Lebwohl, M., L. . Kircik, A. Moore, L. Stein Gold, J. Del Rosso, Z. Draelos, M. Gooderham, L. Green, A. Herbert, K. Papp, J. . Bagel, N. Bhatia, L. Ferris, T. . Jones, S. Kempers, D. Pariser, P. Yamauchi, M. Zirwas, A. . Feng, P. Burnett, R. Higham, and D. Berk. “Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s42, doi:10.25251/skin.5.supp.42.